Data Science Funding Announcements & Notices
Data science and informatics funding announcements and notices are available from NCI and NIH programs. Browse below for opportunities, requests for information, notices, and initiatives.
| Title Sort ascending | FOA | Organization | Release Date | Expire Date | Purpose |
|---|---|---|---|---|---|
| Technology Development Research for Establishing Feasibility and Proof of Concept (R21 - Clinical Trial Not Allowed) | PAR-22-126 | NIGMS | This initiative will support exploratory research leading to the development of innovative technologies for biomedical research. The program will recognize and reward high risk approaches with… More | ||
| Technologies for Improving Minority Health and Eliminating Health Disparities (R41/R42- Clinical Trial Optional) | RFA-MD-24-007 | NIMHD | This Notice of Funding Opportunity (NOFO) invites eligible United States small business concerns (SBCs) to submit Small Business Technology Transfer (STTR) grant applications that propose to develop… More | ||
| Technologies and Assays for Therapeutic Genome Editing INDs (U01, Clinical Trial Not Allowed) | RFA-RM-24-007 | RMOD | The purpose of this Notice Of Funding Opportunity (NOFO) is to solicit applications on the optimization and characterization of technologies and assays with the potential for utilization and adoption… More | ||
| Team-Based Design in Biomedical Engineering Education (R25 Clinical Trial Not Allowed) | PAR-22-000 | NIBIB | The NIH Research Education Program (R25) supports research education activities in the mission areas of the NIH. The over-arching goal of this NIBIB R25 program is to support educational activities… More | ||
| Targeting Inflammasomes in HIV and Substance Use (R21 Clinical Trial Not Allowed) | RFA-DA-25-013 | NIDA | The scientific objective of this Funding Opportunity Announcement is to encourage research to delineate the role of inflammasomes in the neuropathology produced by acute or chronic drug exposure and… More | ||
| Targeting Inflammasomes in HIV and Substance Use (R01 Clinical Trial Not Allowed) | RFA-DA-25-012 | NIDA | The scientific objective of this Notice of Funding Opportunity is to encourage research to delineate the role of inflammasomes in the neuropathology produced by acute or chronic drug exposure and HIV… More | ||
| Tailoring HIV Curative Strategies to the Participant (UM1 Clinical Trial Not Allowed) | RFA-AI-24-011 | NIAID | The purpose of this Notice of Funding Opportunity (NOFO) is to support the development of clinical research platforms that will enable future clinical trials to determine whether combinations of HIV… More | ||
| Systematic Testing of Radionuclides in Preclinical Experiments (STRIPE) (R21 Clinical Trial Not Allowed) | PAR-22-140 | NCI | The STRIPE program seeks to support pre-clinical research projects utilizing state-of-the-art cancer biology methods and model systems that study how radiopharmaceutical therapy (RPT) agents affect… More | ||
| Systematic Testing of Radionuclides in Preclinical Experiments (STRIPE) (R01 Clinical Trial Not Allowed) | PAR-22-139 | NCI | The purpose of this Funding Opportunity Announcement (FOA) is to solicit R01 research projects utilizing state-of-the-art cancer biology methods and model systems to study effects of different types… More | ||
| Sustained Support for Informatics Technologies for Cancer Research and Management (U24 Clinical Trial Optional) | RFA-CA-24-019 | NCI | The purpose of this Funding Opportunity Announcement (FOA) is to invite Cooperative Agreement (U24) applications for the continued development and sustainment of high-value informatics research… More |